A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.

Innocenti F, Owzar K, Cox NL, Evans P, Kubo M, Zembutsu H, Jiang C, Hollis D, Mushiroda T, Li L, Friedman P, Wang L, Glubb D, Hurwitz H, Giacomini KM, McLeod HL, Goldberg RM, Schilsky RL, Kindler HL, Nakamura Y, Ratain MJ
Clin Cancer Res. 2012 18 (2): 577-84

PMID: 22142827 · PMCID: PMC3412624 · DOI:10.1158/1078-0432.CCR-11-1387

MeSH Terms (18)

Adenocarcinoma Aged Amino Acid Substitution Antimetabolites, Antineoplastic Clinical Trials, Phase III as Topic Deoxycytidine Double-Blind Method Female Genome-Wide Association Study Humans Interleukin-17 Kaplan-Meier Estimate Linkage Disequilibrium Male Middle Aged Pancreatic Neoplasms Polymorphism, Single Nucleotide Randomized Controlled Trials as Topic

Connections (1)

This publication is referenced by other Labnodes entities: